ES2052075T3 - Composicion farmaceutica liquida para derivados de piperidinoalcanol. - Google Patents
Composicion farmaceutica liquida para derivados de piperidinoalcanol.Info
- Publication number
- ES2052075T3 ES2052075T3 ES90101217T ES90101217T ES2052075T3 ES 2052075 T3 ES2052075 T3 ES 2052075T3 ES 90101217 T ES90101217 T ES 90101217T ES 90101217 T ES90101217 T ES 90101217T ES 2052075 T3 ES2052075 T3 ES 2052075T3
- Authority
- ES
- Spain
- Prior art keywords
- piperidinoalcanol
- pharmaceutical composition
- liquid pharmaceutical
- derivatives
- approximate amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA LIQUIDA CONSISTENTE EN (A) UN PIPERIDINOALCANOL EN UNA CANTIDAD APROXIMADA DE 2 A 25 MM; (B) UN REGULADOR ADECUADO, SELECCIONADO DEL GRUPO QUE CONSTE DE REGULADORES DE ACIDOS GLUCONICO, LACTICO, CITRICO Y ACETICO, EN UNA CANTIDAD APROXIMADA DE 0,001 A 0,5 M; Y (C) AGUA EN UNA CANTIDAD APROXIMADA QUE CUBRA DEL 5 AL 99% DEL PESO DE LA COMPOSICION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30038289A | 1989-01-23 | 1989-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2052075T3 true ES2052075T3 (es) | 1994-07-01 |
Family
ID=23158874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90101217T Expired - Lifetime ES2052075T3 (es) | 1989-01-23 | 1990-01-22 | Composicion farmaceutica liquida para derivados de piperidinoalcanol. |
Country Status (21)
Country | Link |
---|---|
US (1) | US5049568A (es) |
EP (1) | EP0380023B1 (es) |
JP (1) | JP2873595B2 (es) |
KR (1) | KR0147821B1 (es) |
CN (1) | CN1022023C (es) |
AR (1) | AR245888A1 (es) |
AT (1) | ATE102034T1 (es) |
AU (1) | AU621707B2 (es) |
CA (1) | CA2008183C (es) |
DE (1) | DE69006863T2 (es) |
DK (1) | DK0380023T3 (es) |
ES (1) | ES2052075T3 (es) |
FI (1) | FI95348C (es) |
HU (1) | HU215962B (es) |
IE (1) | IE63168B1 (es) |
IL (1) | IL93097A0 (es) |
NO (1) | NO177126C (es) |
NZ (1) | NZ232167A (es) |
PH (1) | PH27184A (es) |
PT (1) | PT92922B (es) |
ZA (1) | ZA90341B (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2107375A1 (es) * | 1995-08-01 | 1997-11-16 | Almirall Lab | Formulaciones farmaceuticas liquidas de ebastina por via oral. |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003976A1 (en) * | 1994-08-01 | 1996-02-15 | Kv Pharmaceutical Corporation | Tastemasked liquid pharmaceutical delivery system |
KR100405116B1 (ko) * | 1995-02-28 | 2004-02-05 | 아벤티스 파마슈티칼스 인크. | 피페리디노알칸올화합물에대한약제학적조성물 |
US5574045A (en) * | 1995-06-06 | 1996-11-12 | Hoechst Marion Roussel, Inc. | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
CZ295461B6 (cs) * | 1997-08-26 | 2005-08-17 | Aventis Pharmaceuticals Inc. | Farmaceutický prostředek ve formě dvouvrstvé tablety |
GB9802617D0 (en) * | 1998-02-07 | 1998-04-01 | Knoll Ag | Pharmaceutical formulation |
GB9822170D0 (en) * | 1998-10-13 | 1998-12-02 | Danbioyst Uk Ltd | Novel formulations of fexofenadine |
IL148292A (en) * | 2002-02-21 | 2008-08-07 | Shai Yarkoni | Stable preparations of lupoginone and other quinazolinone derivatives |
WO2015001478A1 (en) * | 2013-07-01 | 2015-01-08 | Aventis Pharmaceuticals Inc. | Liquid pharmaceutical composition for oral administration comprising fexofenadine |
JP2022537478A (ja) * | 2019-04-05 | 2022-08-26 | ジェディア バイオテック エービー | 膣錠剤製剤 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
US3966949A (en) * | 1973-10-12 | 1976-06-29 | Richardson-Merrell Inc. | Pharmaceutical compositions and preparing same |
US4139627A (en) * | 1977-10-06 | 1979-02-13 | Beecham Inc. | Anesthetic lozenges |
US4285957A (en) * | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof |
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
DK164642C (da) * | 1984-08-30 | 1992-12-14 | Merrell Dow Pharma | Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler |
US4912117A (en) * | 1985-07-02 | 1990-03-27 | Merrell Dow Pharmaceuticals Inc. | Novel chemical compounds |
US4783471A (en) * | 1985-07-02 | 1988-11-08 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl piperidine methanol derivatives and the uses thereof |
FR2588556B1 (fr) * | 1985-10-11 | 1988-01-08 | Sanofi Sa | Derives du naphtalene substitues par un groupement (omega-amino) alcanol a activite antimicrobienne, leur preparation et les compositions les contenant |
FR2620704B1 (fr) * | 1987-09-17 | 1991-04-26 | Sanofi Sa | Derives de (benzyl-4 piperidino)-1 propanol-2, leur preparation, leur utilisation comme antimicrobiens et les produits les contenant |
AR240018A1 (es) * | 1987-10-07 | 1990-01-31 | Merrell Pharma Inc | Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol. |
US4929605A (en) * | 1987-10-07 | 1990-05-29 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol derivatives |
US4870083A (en) * | 1987-11-24 | 1989-09-26 | Merrell Dow Pharmaceuticals Inc. | 1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants |
US4808410A (en) * | 1987-12-16 | 1989-02-28 | Richardson-Vicks Inc. | Pharmaceutical compositions containing dyclonine HC1 and phenol |
US4822778A (en) * | 1988-01-19 | 1989-04-18 | Gunnar Aberg | Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds |
-
1990
- 1990-01-17 AR AR90315960A patent/AR245888A1/es active
- 1990-01-17 ZA ZA90341A patent/ZA90341B/xx unknown
- 1990-01-18 AU AU48593/90A patent/AU621707B2/en not_active Ceased
- 1990-01-18 IL IL93097A patent/IL93097A0/xx not_active IP Right Cessation
- 1990-01-19 NZ NZ232167A patent/NZ232167A/xx unknown
- 1990-01-19 CA CA002008183A patent/CA2008183C/en not_active Expired - Fee Related
- 1990-01-22 EP EP90101217A patent/EP0380023B1/en not_active Expired - Lifetime
- 1990-01-22 IE IE23490A patent/IE63168B1/en not_active IP Right Cessation
- 1990-01-22 KR KR1019900000711A patent/KR0147821B1/ko not_active IP Right Cessation
- 1990-01-22 DK DK90101217.9T patent/DK0380023T3/da active
- 1990-01-22 AT AT90101217T patent/ATE102034T1/de not_active IP Right Cessation
- 1990-01-22 DE DE69006863T patent/DE69006863T2/de not_active Expired - Fee Related
- 1990-01-22 HU HU23190A patent/HU215962B/hu not_active IP Right Cessation
- 1990-01-22 PT PT92922A patent/PT92922B/pt not_active IP Right Cessation
- 1990-01-22 NO NO900297A patent/NO177126C/no not_active IP Right Cessation
- 1990-01-22 ES ES90101217T patent/ES2052075T3/es not_active Expired - Lifetime
- 1990-01-22 FI FI900334A patent/FI95348C/fi not_active IP Right Cessation
- 1990-01-23 CN CN90100364A patent/CN1022023C/zh not_active Expired - Fee Related
- 1990-01-23 JP JP2011996A patent/JP2873595B2/ja not_active Expired - Fee Related
- 1990-01-23 PH PH39924A patent/PH27184A/en unknown
- 1990-03-09 US US07/494,887 patent/US5049568A/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2107375A1 (es) * | 1995-08-01 | 1997-11-16 | Almirall Lab | Formulaciones farmaceuticas liquidas de ebastina por via oral. |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ236589A (en) | A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions | |
DK645389A (da) | Phosphinsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse | |
IL66256A0 (en) | Water containing compositions comprising salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants | |
SE8901041D0 (sv) | Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning | |
GB9218779D0 (en) | Antiperspirant actives and compositions | |
ES2052075T3 (es) | Composicion farmaceutica liquida para derivados de piperidinoalcanol. | |
DE3775922D1 (de) | Kosmetische zubereitungen, die elastinderivate enthalten. | |
ITMI931326A1 (it) | Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico | |
ES2092868T3 (es) | Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante. | |
MX159192A (es) | Una composicion detergente liquida que es suave para la piel | |
ATE110736T1 (de) | Phosphonsäure-derivate von steroiden als hemmstoffe der 5-alpha-reduktase. | |
ES2053511T3 (es) | Derivados de acidos aminocarboxilicos biciclicos, procedimiento y productos intermedios para su preparacion, asi como su empleo. | |
ES8705763A1 (es) | Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos | |
NO891220D0 (no) | Middel som inneholder salicylsyre for behandling av lepidose. | |
SE8800988D0 (sv) | Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same | |
FI951378A (fi) | N-asetyyli-neuramiinihapon johdannaisten synteesi | |
DK0471718T3 (da) | Paracetamolholdigt farmaceutisk præparat | |
MY118074A (en) | Soap bar composition. | |
IL72668A (en) | Hydroxyalkyl(and hydroxyalkoxy)benzoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
JPS57200361A (en) | "indomethacin(r)" pharmaceutical with low irritant action | |
ATE130628T1 (de) | Antioxydantsystem auf basis einer basischen aminosäure und eines tocopherols. | |
NO903291D0 (no) | Renin-hemmende aminooligohydroksy-derivater. | |
ES2014445B3 (es) | Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos. | |
KR930012023A (ko) | 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법 | |
GB1153206A (en) | Preparation of Substituted alpha-Phenylalkanoic Acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 380023 Country of ref document: ES |